Palisade’s Blockbuster Raise and Kraig’s Next-Gen Textiles Light Up the Morning

October 1, 2025

DENVER, Colo., Oct 01, 2025 (247marketnews.com)- Here’s a look at the morning’s biggest storylines across small-cap stocks making headlines and moving early:

Clinical-stage biotech Palisade Bio (NASDAQ:PALI) is dominating small-cap biotech chatter after pricing an upsized $120 million underwritten public offering of 171.4 million shares at $0.70 per share. The raise comes with a 45-day option for underwriters to scoop up another 25.7 million shares, giving the company a substantial capital injection to advance its pipeline targeting autoimmune and fibrotic diseases.

The offering is expected to close tomorrow and gives Palisade significant runway to fund trials, and possibly explore strategic opportunities in the high-need immunology space.

Kraig Biocraft Laboratories (OTCQB:KBLB) is weaving headlines with its recombinant spider silk, which is now being tested by three gear and apparel companies, two in the sports sector. Known for its lightweight strength, elasticity, and thermoregulation, spider silk is tailor-made for performance wear in snowboarding, cycling, and high-impact sports.

As the $400B+ global sportswear market chases next-gen materials, Kraig’s scalable spider silk platform could thread the needle between performance and sustainability. With smart textiles also in play, KBLB’s material science pivot is stitching it into the conversation around wearable tech and high-performance gear.

NUBURU (NYSE:BURU), a developer of high-power blue lasers for precision metal processing, remains on watchlists as industrial players seek next-gen welding tech for battery production, aerospace, and defense. BURU’s patented blue laser tech offers higher speed and better welds for copper and aluminum, critical for EVs and electronics, keeping it in focus as supply chains demand more efficient manufacturing tools.

Kaival Brands (NASDAQ:KAVL), the exclusive U.S. distributor of BIDI Stick disposable e-cigs, is seeing renewed interest as regulatory visibility improves and investors revisit small-cap consumer names. Recent cost cuts and revenue diversification efforts, including non-nicotine product lines, could help Kaival reposition within a volatile but lucrative vape category.

Healthcare Triangle (NASDAQ:HCTI) is positioning at the intersection of healthcare cloud, data compliance, and AI, three sectors all drawing institutional capital. While news has been sparse, its links to AWS and Google Cloud, along with its SaaS offerings for hospital networks, keep it in the conversation as a potential long-term bet on healthcare digital transformation.

Beyond Meat (NASDAQ:BYND) continues to bounce along 52-week lows, with investors hoping for a strategic reset amid inflation-driven consumer pullback and growing competition..

Intensity Therapeutics (NASDAQ:INTS), known for its intratumoral immunotherapy INT230-6, hasn’t released new data since ASCO earlier this year, but the biotech remains on radar as trials progress. With preclinical data showing tumor regression and systemic immune activation, it’s a sleeper candidate in the immune-oncology pipeline.

PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated by one or more featured companies for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. Please go to https://247marketnews.com/kblb-disclosure/ for further KBLB and 247marketnews.com disclosure information.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (KBLB, BURU, PALI, BYND, IBAC, KAVL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.